Selected research
Industry Research
Single B Cell Antibody Screening Service Industry Research Report 2026
Market perspective
The global Single B Cell Antibody Screening Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Single B Cell Antibody Screening Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Single B Cell Antibody Screening Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Single B Cell Antibody Screening Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Single B Cell Antibody Screening Service include Creative Biolabs, Curia, GenScript, Sino Biological,Inc., Shanghai Chempartner Lifescience Co., Ltd., Biointron Biological Inc., Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., Beijing Biosynthesis Biotechnology Co., Ltd. and Automated Lab Solutions, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Single B Cell Antibody Screening Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Single B Cell Antibody Screening Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Single B Cell Antibody Screening Service Market by Company
Creative Biolabs
Curia
GenScript
Sino Biological,Inc.
Shanghai Chempartner Lifescience Co., Ltd.
Biointron Biological Inc.
Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
Beijing Biosynthesis Biotechnology Co., Ltd.
Automated Lab Solutions
SAFE Pharmaceutical Technology Co., Ltd.
Nanjing Zoonbio Biotechnology Co., Ltd.
Single B Cell Antibody Screening Service Segment by Type
Customized Service
Functional Screening
Others
Single B Cell Antibody Screening Service Segment by Application
Drug Discovery
Biological Engineering
Clinical Diagnosis
Immune Research
Others
Single B Cell Antibody Screening Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single B Cell Antibody Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Single B Cell Antibody Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single B Cell Antibody Screening Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Single B Cell Antibody Screening Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Customized Service
- Functional Screening
- Others
Applications
- Drug Discovery
- Biological Engineering
- Clinical Diagnosis
- Immune Research
- Others
Companies covered
- Creative Biolabs
- Curia
- GenScript
- Sino Biological,Inc.
- Shanghai Chempartner Lifescience Co., Ltd.
- Biointron Biological Inc.
- Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
- Beijing Biosynthesis Biotechnology Co., Ltd.
- Automated Lab Solutions
- SAFE Pharmaceutical Technology Co., Ltd.
- Nanjing Zoonbio Biotechnology Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Single B Cell Antibody Screening Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Customized Service
- 2.2.3 Functional Screening
- 2.2.4 Others
- 2.3 Single B Cell Antibody Screening Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug Discovery
- 2.3.3 Biological Engineering
- 2.3.4 Clinical Diagnosis
- 2.3.5 Immune Research
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Single B Cell Antibody Screening Service Breakdown Data by Type
- 3.1 Global Single B Cell Antibody Screening Service Historic Market Size by Type (2021-2026)
- 3.2 Global Single B Cell Antibody Screening Service Forecasted Market Size by Type (2027-2032)
4 Single B Cell Antibody Screening Service Breakdown Data by Application
- 4.1 Global Single B Cell Antibody Screening Service Historic Market Size by Application (2021-2026)
- 4.2 Global Single B Cell Antibody Screening Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Single B Cell Antibody Screening Service Market Perspective (2021-2032)
- 5.2 Global Single B Cell Antibody Screening Service Growth Trends by Region
- 5.2.1 Global Single B Cell Antibody Screening Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Single B Cell Antibody Screening Service Historic Market Size by Region (2021-2026)
- 5.2.3 Single B Cell Antibody Screening Service Forecasted Market Size by Region (2027-2032)
- 5.3 Single B Cell Antibody Screening Service Market Dynamics
- 5.3.1 Single B Cell Antibody Screening Service Industry Trends
- 5.3.2 Single B Cell Antibody Screening Service Market Drivers
- 5.3.3 Single B Cell Antibody Screening Service Market Challenges
- 5.3.4 Single B Cell Antibody Screening Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Single B Cell Antibody Screening Service Players by Revenue
- 6.1.1 Global Top Single B Cell Antibody Screening Service Players by Revenue (2021-2026)
- 6.1.2 Global Single B Cell Antibody Screening Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Single B Cell Antibody Screening Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Single B Cell Antibody Screening Service Head Office and Area Served
- 6.4 Global Single B Cell Antibody Screening Service Players, Product Type & Application
- 6.5 Global Single B Cell Antibody Screening Service Manufacturers Established Date
- 6.6 Global Single B Cell Antibody Screening Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Single B Cell Antibody Screening Service Market Size (2021-2032)
- 7.2 North America Single B Cell Antibody Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Single B Cell Antibody Screening Service Market Size by Country (2021-2026)
- 7.4 North America Single B Cell Antibody Screening Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Single B Cell Antibody Screening Service Market Size (2021-2032)
- 8.2 Europe Single B Cell Antibody Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Single B Cell Antibody Screening Service Market Size by Country (2021-2026)
- 8.4 Europe Single B Cell Antibody Screening Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Single B Cell Antibody Screening Service Market Size (2021-2032)
- 9.2 Asia-Pacific Single B Cell Antibody Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Single B Cell Antibody Screening Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Single B Cell Antibody Screening Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Single B Cell Antibody Screening Service Market Size (2021-2032)
- 10.2 South America Single B Cell Antibody Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Single B Cell Antibody Screening Service Market Size by Country (2021-2026)
- 10.4 South America Single B Cell Antibody Screening Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Single B Cell Antibody Screening Service Market Size (2021-2032)
- 11.2 Middle East & Africa Single B Cell Antibody Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Single B Cell Antibody Screening Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Single B Cell Antibody Screening Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Creative Biolabs
- 12.1.1 Creative Biolabs Company Information
- 12.1.2 Creative Biolabs Business Overview
- 12.1.3 Creative Biolabs Revenue in Single B Cell Antibody Screening Service Business (2021-2026)
- 12.1.4 Creative Biolabs Single B Cell Antibody Screening Service Product Portfolio
- 12.1.5 Creative Biolabs Recent Developments
- 12.2 Curia
- 12.2.1 Curia Company Information
- 12.2.2 Curia Business Overview
- 12.2.3 Curia Revenue in Single B Cell Antibody Screening Service Business (2021-2026)
- 12.2.4 Curia Single B Cell Antibody Screening Service Product Portfolio
- 12.2.5 Curia Recent Developments
- 12.3 GenScript
- 12.3.1 GenScript Company Information
- 12.3.2 GenScript Business Overview
- 12.3.3 GenScript Revenue in Single B Cell Antibody Screening Service Business (2021-2026)
- 12.3.4 GenScript Single B Cell Antibody Screening Service Product Portfolio
- 12.3.5 GenScript Recent Developments
- 12.4 Sino Biological,Inc.
- 12.4.1 Sino Biological,Inc. Company Information
- 12.4.2 Sino Biological,Inc. Business Overview
- 12.4.3 Sino Biological,Inc. Revenue in Single B Cell Antibody Screening Service Business (2021-2026)
- 12.4.4 Sino Biological,Inc. Single B Cell Antibody Screening Service Product Portfolio
- 12.4.5 Sino Biological,Inc. Recent Developments
- 12.5 Shanghai Chempartner Lifescience Co., Ltd.
- 12.5.1 Shanghai Chempartner Lifescience Co., Ltd. Company Information
- 12.5.2 Shanghai Chempartner Lifescience Co., Ltd. Business Overview
- 12.5.3 Shanghai Chempartner Lifescience Co., Ltd. Revenue in Single B Cell Antibody Screening Service Business (2021-2026)
- 12.5.4 Shanghai Chempartner Lifescience Co., Ltd. Single B Cell Antibody Screening Service Product Portfolio
- 12.5.5 Shanghai Chempartner Lifescience Co., Ltd. Recent Developments
- 12.6 Biointron Biological Inc.
- 12.6.1 Biointron Biological Inc. Company Information
- 12.6.2 Biointron Biological Inc. Business Overview
- 12.6.3 Biointron Biological Inc. Revenue in Single B Cell Antibody Screening Service Business (2021-2026)
- 12.6.4 Biointron Biological Inc. Single B Cell Antibody Screening Service Product Portfolio
- 12.6.5 Biointron Biological Inc. Recent Developments
- 12.7 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
- 12.7.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information
- 12.7.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview
- 12.7.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Revenue in Single B Cell Antibody Screening Service Business (2021-2026)
- 12.7.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Single B Cell Antibody Screening Service Product Portfolio
- 12.7.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Developments
- 12.8 Beijing Biosynthesis Biotechnology Co., Ltd.
- 12.8.1 Beijing Biosynthesis Biotechnology Co., Ltd. Company Information
- 12.8.2 Beijing Biosynthesis Biotechnology Co., Ltd. Business Overview
- 12.8.3 Beijing Biosynthesis Biotechnology Co., Ltd. Revenue in Single B Cell Antibody Screening Service Business (2021-2026)
- 12.8.4 Beijing Biosynthesis Biotechnology Co., Ltd. Single B Cell Antibody Screening Service Product Portfolio
- 12.8.5 Beijing Biosynthesis Biotechnology Co., Ltd. Recent Developments
- 12.9 Automated Lab Solutions
- 12.9.1 Automated Lab Solutions Company Information
- 12.9.2 Automated Lab Solutions Business Overview
- 12.9.3 Automated Lab Solutions Revenue in Single B Cell Antibody Screening Service Business (2021-2026)
- 12.9.4 Automated Lab Solutions Single B Cell Antibody Screening Service Product Portfolio
- 12.9.5 Automated Lab Solutions Recent Developments
- 12.10 SAFE Pharmaceutical Technology Co., Ltd.
- 12.10.1 SAFE Pharmaceutical Technology Co., Ltd. Company Information
- 12.10.2 SAFE Pharmaceutical Technology Co., Ltd. Business Overview
- 12.10.3 SAFE Pharmaceutical Technology Co., Ltd. Revenue in Single B Cell Antibody Screening Service Business (2021-2026)
- 12.10.4 SAFE Pharmaceutical Technology Co., Ltd. Single B Cell Antibody Screening Service Product Portfolio
- 12.10.5 SAFE Pharmaceutical Technology Co., Ltd. Recent Developments
- 12.11 Nanjing Zoonbio Biotechnology Co., Ltd.
- 12.11.1 Nanjing Zoonbio Biotechnology Co., Ltd. Company Information
- 12.11.2 Nanjing Zoonbio Biotechnology Co., Ltd. Business Overview
- 12.11.3 Nanjing Zoonbio Biotechnology Co., Ltd. Revenue in Single B Cell Antibody Screening Service Business (2021-2026)
- 12.11.4 Nanjing Zoonbio Biotechnology Co., Ltd. Single B Cell Antibody Screening Service Product Portfolio
- 12.11.5 Nanjing Zoonbio Biotechnology Co., Ltd. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst